Cue, Google’s COVID-19 test provider, raises $200M in IPO
The at-home test maker will use the money to scale up commercial and manufacturing infrastructure to support its portable diagnostic platform. Cue Health’s Friday debut on the Nasdaq valued the company at $2.9 billion.